Login Register Cart 0
Generic placeholder image

Current Drug Therapy

Editor-in-Chief

ISSN (Print): 1574-8855
ISSN (Online): 2212-3903

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Formulation and Evaluation of Hard Lozenges by Using Garlic Tincture

Author(s): Anmol Popli, Uditi Handa*, Kuldeep Kumar, Prerna Sharma, Kumar Guarve, Ishika Parmar, Lavish Chhabra, Kajal Nagpal, Nidhi Rani* and Inderjeet Verma

Volume 20, Issue 2, 2025

Published on: 07 March, 2024

Page: [189 - 195] Pages: 7

DOI: 10.2174/0115748855258962230920111057

Price: $65

Abstract

Background: Lozenges are one of the more well-liked and inventive oral confectionery products in the market. The lozenges also act as solid medications that are flavored, sweetened, and meant to be sucked into the mouth/pharynx or held over that cavity. Garlic contains anti-microbial agents which help to reduce the impact of cough and reduce it.

Aims: The goal of the current research is to formulate and investigate herbal lozenges by using garlic tinctures with their antimicrobial action to cure the infection caused by microbes.

Methods: Hard lozenges were prepared by Heating and congealing techniques and statistical analysis was done by using one sample chi-square test (IBM SPSS version 20).

Results: Hard lozenges were formulated by using garlic tinctures with minimum excipients. According to ICH recommendations, stability experiments were conducted. According to the stability investigations, there were no major changes noticed during the period after the one-month stability test. The antimicrobial activity was studied under different time intervals after 8-72 hours. The inhibition zone value for the test sample was found to be 0.1-0.5 mm and for the standard sample was noticed from 0.5-0.8 mm, respectively. The statistical test outcome revealed, no remarkable difference shown between the prepared and the marketed formulation (p<0.05).

Conclusion: From the present work, it was concluded that the prepared lozenges have similar result with minimum ingredients as compared to the marketed formulation (Tulsi-ginger lozenges). Hence, the formulation, testing, and antimicrobial activity for oral use in garlic lozenges were effective.

Keywords: Lozenges, garlic tincture, preparation of lozenges, evaluation test, stability studies, antimicrobial activity.

« Previous Next »
Graphical Abstract

[1]
Apurva PD, Shrikant TK. MM BD. Medicated chewable lozenges: A review. Int J Recent Sci Res 2019; 10(04): 32071-6.
[2]
British Pharmacopoeia Commission British Pharmacopoeia 2018. (9th ed.). London: Stationery Office 2018; 3: p. 63.
[3]
Sastry SV, Nyshadham JR, Fix JA. Recent technological advances in oral drug delivery - A review. Pharm Sci Technol Today 2000; 3(4): 138-45.
[http://dx.doi.org/10.1016/S1461-5347(00)00247-9] [PMID: 10754543]
[4]
Majekodunmi SO. Lozenges: A review. Am J Med Med Sci 2015; 5(2): 99-104.
[5]
Koseoglu M, Isleten F, Atay A, Kaplan YC. Effects of acute and subacute garlic supplement administration on serum total antioxidant capacity and lipid parameters in healthy volunteers. Phytother Res 2010; 24(3): 374-8.
[http://dx.doi.org/10.1002/ptr.2953] [PMID: 19653315]
[6]
M S U S R D, R R K S L, N D . Chewable lozenge formulation: A review. Int Res J Pharma 2016; 7(4): 9-16.
[http://dx.doi.org/10.7897/2230-8407.07432]
[7]
Kundaković T, Ćirić A, Soković M, Milenković M, Nikolić V, Nikolić G. Antimicrobial activity of the lozenge with garlic bulb powder. Hem Ind 2011; 65(5): 607-10.
[http://dx.doi.org/10.2298/HEMIND110414048K]
[8]
Aviello G, Abenavoli L, Borrelli F, et al. Garlic: Empiricism or science. Nat Prod Commun 2009; 4(12): 1934578X0900401231.
[http://dx.doi.org/10.1177/1934578X0900401231]
[9]
Fujisawa H, Watanabe K, Suma K, et al. Antibacterial potential of garlic-derived allicin and its cancellation by sulfhydryl compounds. Biosci Biotechnol Biochem 2009; 73(9): 1948-55.
[http://dx.doi.org/10.1271/bbb.90096] [PMID: 19734685]
[10]
Pyun MS, Shin S. Antifungal effects of the volatile oils from Allium plants against Trichophyton species and synergism of the oils with ketoconazole. Phytomedicine 2006; 13(6): 394-400.
[http://dx.doi.org/10.1016/j.phymed.2005.03.011] [PMID: 16716908]
[11]
Gautam R, Saklani A, Jachak SM. Indian medicinal plants as a source of antimycobacterial agents. J Ethnopharmacol 2007; 110(2): 200-34.
[http://dx.doi.org/10.1016/j.jep.2006.12.031] [PMID: 17276637]
[12]
Sivam GP, Lampe JW, Ulness B, Swanzy SR, Potter JD. Helicobacter pylori-in vitro susceptibility to garlic (Allium sativum) extract. Nutr Cancer 1997; 27(2): 118-21.
[http://dx.doi.org/10.1080/01635589709514512] [PMID: 9121937]
[13]
Ankri S, Mirelman D. Antimicrobial properties of allicin from garlic. Microbes Infect 1999; 1(2): 125-9.
[http://dx.doi.org/10.1016/S1286-4579(99)80003-3] [PMID: 10594976]
[14]
Sirtori CR, Galli C, Anderson JW, Sirtori E, Arnoldi A. Functional foods for dyslipidaemia and cardiovascular risk prevention. Nutr Res Rev 2009; 22(2): 244-61.
[http://dx.doi.org/10.1017/S0954422409990187] [PMID: 20003590]
[15]
Clement F, Venkatesh YP. Dietary garlic (Allium sativum) lectins, ASA I and ASA II, are highly stable and immunogenic. Int Immunopharmacol 2010; 10(10): 1161-9.
[http://dx.doi.org/10.1016/j.intimp.2010.06.022] [PMID: 20615490]
[16]
Iciek M, Kwiecień I, Włodek L. Biological properties of garlic and garlic-derived organosulfur compounds. Environ Mol Mutagen 2009; 50(3): 247-65.
[http://dx.doi.org/10.1002/em.20474] [PMID: 19253339]
[17]
Rahman MS. Allicin and other functional active components in garlic: Health benefits and bioavailability. Int J Food Prop 2007; 10(2): 245-68.
[http://dx.doi.org/10.1080/10942910601113327]
[18]
Borlinghaus J, Albrecht F, Gruhlke M, Nwachukwu I, Slusarenko A. Allicin: Chemistry and biological properties. Molecules 2014; 19(8): 12591-618.
[http://dx.doi.org/10.3390/molecules190812591] [PMID: 25153873]
[19]
Yoshida S, Kasuga S, Hayashi N, Ushiroguchi T, Matsuura H, Nakagawa S. Antifungal activity of ajoene derived from garlic. Appl Environ Microbiol 1987; 53(3): 615-7.
[http://dx.doi.org/10.1128/aem.53.3.615-617.1987] [PMID: 3555334]
[20]
Amagase H, Petesch BL, Matsuura H, Kasuga S, Itakura Y. Intake of garlic and its bioactive components. J Nutr 2001; 131(3): 955S-62S.
[http://dx.doi.org/10.1093/jn/131.3.955S] [PMID: 11238796]
[21]
Khanum F, Anilakumar KR, Viswanathan KR. Anticarcinogenic properties of garlic: A review. Crit Rev Food Sci Nutr 2004; 44(6): 479-88.
[http://dx.doi.org/10.1080/10408690490886700] [PMID: 15615431]
[22]
Rose P, Whiteman M, Moore PK, Zhu YZ. Bioactive S-alk(en)yl cysteine sulfoxide metabolites in the genus Allium: The chemistry of potential therapeutic agents. Nat Prod Rep 2005; 22(3): 351-68.
[http://dx.doi.org/10.1039/b417639c] [PMID: 16010345]
[23]
Bhatwalkar SB, Mondal R, Krishna SBN, Adam JK, Govender P, Anupam R. Antibacterial properties of organosulfur compounds of garlic (Allium sativum). Front Microbiol 2021; 12: 613077.
[http://dx.doi.org/10.3389/fmicb.2021.613077] [PMID: 34394014]
[24]
Mikaili P, Maadirad S, Moloudizargari M, Aghajanshakeri S, Sarahroodi S. Therapeutic uses and pharmacological properties of garlic, shallot, and their biologically active compounds. Iran J Basic Med Sci 2013; 16(10): 1031-48.
[PMID: 24379960]
[25]
Pratibha KP, Handa U, Nagpal K, Dhiman S, Guarve K. Effectiveness of herbal tinctures formulated into lozenges: A current stipulation in pediatric patients. Int J Early Childhood Spec Educ 2022; 14(5): 1308-5581.
[26]
Ilic D, Nikolic V, Nikolić L, Stanković M, Stanojević L. Thermal degradation, antioxidant and antimicrobial activity of the synthesized allicin and allicin incorporated in gel. Hem Ind 2010; 64(2): 85-91.
[http://dx.doi.org/10.2298/HEMIND091111003I]
[27]
Maryadele J, Heckelman PE, Koch CB, Roman KJ, Eds. The Merck Index: An encyclopedia of chemicals, drugs and biologicals. Whitehouse Station, NJ: Merck & Co. 2006; pp. 69-78.
[28]
Pothu R, Aparna A, Rao YM. Development and in-vitro evaluation of chlorhexidine and flurbiprofen hard candy lozenges. Int J Pharm Sci Res 2015; 6(8): 3380-90.
[29]
Aulton ME, Wells TI. Pharmaceutics, The science of Dosage Form Design. (1st ed.), Livingston, London: Churchill Livingstone 1988.
[30]
Khudhair DB, Ali WK. Formulation and evaluation of Acy-clovir compressed lozenges. Al Mustansiriyah J Pharmaceut Sci 2022; 20(4): 35-44.
[http://dx.doi.org/10.32947/ajps.v20i4.772]
[31]
Chanda R, Nallaguntla L. Formulation and evaluation of medicated lozenges for sore throat. Asian J Pharm Clin Res 2020; 13(10): 62-7.
[http://dx.doi.org/10.22159/ajpcr.2020.v13i10.38660]
[32]
Babasaheb Kolap M, Kisan Omase P, Dashwant AV, Namde RS. Review on Lozenges. Res J Pharmacol Pharma 2021; 13(2): 75-8.
[http://dx.doi.org/10.52711/2321-5836.2021.00016]
[33]
James P. Medicated lozenges. BMJ 1880; 2(1040): 880.
[http://dx.doi.org/10.1136/bmj.2.1040.880] [PMID: 20749728]
[34]
Vega E, Egea MA, Calpena AC, Espina M, García ML. Role of hydroxypropyl-β-cyclodextrin on freeze-dried and gamma-irradiated PLGA and PLGA–PEG diblock copolymer nanospheres for ophthalmic flurbiprofen delivery. Int J Nanomedicine 2012; 7: 1357-71.
[http://dx.doi.org/10.2147/IJN.S28481] [PMID: 22457594]
[35]
Government of India, Ministry of Health and Family Welfare Indian Pharmacopoeia Ghaziabad 2018; II-IV.
[36]
Bajelan E, Kamali-nejad M, Mohsen Foroutan S, Albasha H. Formulation and physicochemical evaluation of lozenge tablets containing Salvia offi cinalis. J Young Pharm 2014; 6(1): 34-8.
[http://dx.doi.org/10.5530/jyp.2014.1.6]
[37]
Damian L, Patachia S. Method for testing the antimicrobial character of the materials and their fitting to the scope. Bull Transilv Univ Brasov Eng Sci 2014; 7(2): 37.
[38]
Charles OE, Festus BCO, Damian CO, Chukwuemeka SN, Peace OO, Ejogha PW. In vitro antimicrobial evaluation of lozenges containing extract of garlic and ginger. Int J Health Res 2010; 3(2): 105-10.

Rights & Permissions Print Cite
Article Metrics
5
1
Wayfinder Image
© 2024 Bentham Science Publishers | Privacy Policy